# BETHKIS

NDC: 10122-820
Generic name: tobramycin
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: RESPIRATORY (INHALATION)
Marketing started: 20130415

FDA application: NDA201820

## Active ingredients

- TOBRAMYCIN: 300 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd3d47b-025f-4705-9daf-cf07725ec223